Our analysis gives an overview on the SNP landscape of NYBR1 and now provides the basis to further study the association of SNPs and the molecular breast cancer subtypes “Her2”, “Luminal A/B” and “Triple negative” as well as clinical data, such as treatment response, relapse rate and overall survival. The gene discussed is ANKRD30A; the disease is breast cancer.